Key Market Segments:
By Product & Services
-
Product
-
Production Services
By Application
-
-
Drug Discovery & Development
-
Therapeutics
-
Research
-
Others
-
By End-user
-
-
Pharmaceutical & Biotechnology Companies
-
Academic & Research Institutes
-
Diagnostic Laboratories
-
Others
-
By Host-cells
-
-
Mammalian Systems
-
Insect Cells
-
Yeast & Fungi
-
Bacterial Cells
-
Others
-
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Eastern Europe
-
Poland
-
Romania
-
Hungary
-
Turkey
-
Rest of Eastern Europe
-
-
Western Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Netherlands
-
Switzerland
-
Austria
-
Rest of Western Europe
-
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Vietnam
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
Middle East
-
UAE
-
Egypt
-
Saudi Arabia
-
Qatar
-
Rest of the Middle East
Africa
-
Nigeria
-
South Africa
-
Rest of Africa
Latin America
-
Brazil
-
Argentina
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Product Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Product Matrix which gives a detailed comparison of the product portfolio of each company
-
Geographic Analysis
-
Additional countries in any of the regions
-
Company Information
-
Detailed analysis and profiling of additional market players (Up to five)
Frequently Asked Questions
The products segment dominated the recombinant proteins market with a share of 67.5% in 2023.
increased research activities for medication development and precision medicine, rising use of biologics and biosimilars, and increasing spending in research & development activities.
Recombinant proteins market size was valued at USD 2.5 billion in 2023.
According to our analysis, the recombinant proteins market is anticipated to reach USD 5.0 billion By 2032.
The recombinant proteins market is expected to grow at 7.6%CAGR from 2024 to 2032.